Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP893453.RAOPfw0GA92N2VldS6fgotYO_4a4TPGo3EdmJPGMUVnnI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP893453.RAOPfw0GA92N2VldS6fgotYO_4a4TPGo3EdmJPGMUVnnI130_assertion type Assertion NP893453.RAOPfw0GA92N2VldS6fgotYO_4a4TPGo3EdmJPGMUVnnI130_head.
- NP893453.RAOPfw0GA92N2VldS6fgotYO_4a4TPGo3EdmJPGMUVnnI130_assertion description "[These results strongly support the utilization of PI3K pathway inhibitors in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP893453.RAOPfw0GA92N2VldS6fgotYO_4a4TPGo3EdmJPGMUVnnI130_provenance.
- NP893453.RAOPfw0GA92N2VldS6fgotYO_4a4TPGo3EdmJPGMUVnnI130_assertion evidence source_evidence_literature NP893453.RAOPfw0GA92N2VldS6fgotYO_4a4TPGo3EdmJPGMUVnnI130_provenance.
- NP893453.RAOPfw0GA92N2VldS6fgotYO_4a4TPGo3EdmJPGMUVnnI130_assertion SIO_000772 21563232 NP893453.RAOPfw0GA92N2VldS6fgotYO_4a4TPGo3EdmJPGMUVnnI130_provenance.
- NP893453.RAOPfw0GA92N2VldS6fgotYO_4a4TPGo3EdmJPGMUVnnI130_assertion wasDerivedFrom befree-2016 NP893453.RAOPfw0GA92N2VldS6fgotYO_4a4TPGo3EdmJPGMUVnnI130_provenance.
- NP893453.RAOPfw0GA92N2VldS6fgotYO_4a4TPGo3EdmJPGMUVnnI130_assertion wasGeneratedBy ECO_0000203 NP893453.RAOPfw0GA92N2VldS6fgotYO_4a4TPGo3EdmJPGMUVnnI130_provenance.